ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0081

Trans-endothelial Trafficking of Fibroblast-like Synoviocytes Amplifies Synovial Inflammation in Rheumatoid Arthritis

Jaeyeon Kim1, Sanaz Panahandeh2, Hieu Nguyen3, Kainat Mian4, Hadijat Makinde4, Kyoung Jae Won5, Arminja Kettenbach3, Harris R Perlman4, Costantino Pitzalis6 and Nunzio Bottini7, 1Cedars Sinai Medical Center, Los Angeles, CA, 2Cedars-Sinai Medical Center, Los Angeles, 3Geisel School of Medicine at Dartmouth, Lebanon, NH, 4Northwestern University, Chicago, IL, 5Cedars-Sinai Medical Center, Los Angeles, CA, 6QMUL, Bromley Kent, United Kingdom, 7Cedars Sinai Medical Center, Beverly Hills, CA

Meeting: ACR Convergence 2025

Keywords: Angiogenesis, autoimmune diseases, Fibroblasts, Synovial, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0067–0097) Rheumatoid Arthritis – Etiology and Pathogenesis Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The discovery of circulating fibroblast-like synoviocyte (FLS), known as PRIME cells, in RA patients suggests that synovial FLS may enter the circulation through blood vessels and contribute to systemic inflammation. This study aimed to detect trans-endothelial migration of FLS and dissect the molecular crosstalk between FLS and endothelial cells (EC) during this process and its relevance in rheumatoid inflammation.

Methods: Human and mouse arthritic synovium were analyzed using immunofluorescence and RNA in situ hybridization (ISH) to identify trans-endothelial migrating FLS. An in vitro trans-endothelial migration model was established using RA FLS and human umbilical vein ECs (HUVEC), followed by transcriptomics and proteomic analysis. Spatial transcriptomics was performed on RA synovial biopsies. Functional experiments were conducted through gene knockdown in vitro and in vivo.

Results: We identified FLS transmigration through EC layers of capillaries in RA synovium, but not in osteoarthritis (OA), which correlated with RA disease activity. ISH confirmed the presence of intravascular FLS in human and mouse arthritic synovium (Fig. 1A, B, C, R2=0.6, P=0.0004). In vitro trans-endothelial migration assay demonstrated that RA FLS actively transmigrate across EC layers. Bulk RNA-seq of trans-endothelial migrated FLS identified increased expression of polycystin-1 (PKD1) (Fig. 2A). Integration of transcriptomics and proteomic data identified cathepsin K (CTSK) as upregulated in EC after transmigration of FLS (Fig 2B), Spatial transcriptomics studies showed that PKD1⁺ FLS are located in close proximity to CTSK⁺ ECs in RA synovium, supporting a spatially organized induction of CTSK by FLS in EC. In vitro assays confirmed that PKD1 knockdown significantly impaired FLS transmigration across EC layers while PKD1 knockdown in FLS reduced the severity of arthritis in vivo (Fig. 3A, B). CTSK knockdown in ECs exposed to FLS impaired angiogenesis while systemic administration of the CTSK inhibitor Odanacatib attenuated joint inflammation and vascular leakage in arthritic mice.

Conclusion: Our findings demonstrate that FLS undergo trans-endothelial migration in RA synovium and identify a mechanism driven by such migration and involving PKD1 and CTSK, which amplifies EC-driven inflammation and RA severity. These results might also provide mechanistic insight into the generation of PRIME cells and highlight FLS–EC spatial interactions as a potential therapeutic target in RA.

Supporting image 1(A) Left: trans-EC migration of RA FLS. Representative microscopy of RA (n=5) synovium subjected to RNA in situ hybridization (ISH) for Podoplanin (PDPN, yellow), Fibroblast Activating Protein (FAP, green), Platelet/Endothelial Cell Adhesion Molecule 1 (PECAM1, red), and Hoechst (blue). Scale bar: 100 µm. Right: Representative quantification of ISH intensities through a capillary (≤ 10 micron) wall and lumen in RA synovium. Data were analyzed using Zen (black edition).

(B) Correlation between the number of intravascular PDPN+ cells in RA biopsies (n=15) and disease activity score (DAS28). Simple linear regression. P=0.0004.

(C) Left: trans-EC migration of mouse FLS. Representative microscopy of serum transfer induced arthritis (STIA) synovium subjected to RNA ISH for Pdpn (yellow), Fap (green), and Pecam1 (red), and Hoechst (blue). Scale bar: 100 µm. Right: Representative quantification of ISH intensities through a capillary (≤ 10 micron) wall and lumen in STIA synovium. Data were analyzed using Zen (black edition).

Supporting image 2(A) Venn diagram from bulk RNA-seq of trans-EC migrated RA FLS (FLSe-Trans) compared to non-migrated FLS (FLSe-nonTrans) or FLS transmigrated without EC (FLSTrans), highlighting a shared set of upregulated genes, including polycystin 1 (PKD1).

(B) Venn diagram from integrated proteomic and transcriptomic analysis of EC co-cultured with RA FLS (ECFLS) compared to EC alone, highlighting upregulated genes, including Cathepsin K (CTSK).

Supporting image 3(A) Left: representative fluorescence microscopy images from an in vitro trans-EC migration assay of RA FLS transfected with PKD1 gRNA-AF647 (cyan) compared to negative control (NC). HUVEC were loaded with 5-chloromethylfluorescein diacetate dye (CMFDA). gRNA-AF647 is cyan, , CMFDA is green, and Hoechst is blue. Right: quantification of trans-EC migrated PKD1 gRNA transfected RA FLS compared to NC gRNA under serum-containing (10% FBS) and serum-free (0.5% BSA) conditions. Each point in A (right) represents an experiment. Two-way ANOVA, Bonferroni’s multiple comparison test. *P < 0.05.

(B) In vivo electroporation using tweezer electrodes and intra-articular injection of Pkd1 gRNA into joints of PDPNcre/+ Cas9 knock-in (KI) fl+/fl+ mice. Clinical arthritis scores (0 – 4) over time in PDPNcre/+ Cas9 KIfl+/fl+ and control mice following intra-articular injection of PKD1 or NC gRNA. Two-way ANOVA, Bonferroni’s multiple comparison test. **P < 0.01.


Disclosures: J. Kim: None; S. Panahandeh: None; H. Nguyen: None; K. Mian: None; H. Makinde: None; K. Won: None; A. Kettenbach: None; H. Perlman: AbbVie/Abbott, 2; C. Pitzalis: None; N. Bottini: Merck/MSD, 2.

To cite this abstract in AMA style:

Kim J, Panahandeh S, Nguyen H, Mian K, Makinde H, Won K, Kettenbach A, Perlman H, Pitzalis C, Bottini N. Trans-endothelial Trafficking of Fibroblast-like Synoviocytes Amplifies Synovial Inflammation in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/trans-endothelial-trafficking-of-fibroblast-like-synoviocytes-amplifies-synovial-inflammation-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trans-endothelial-trafficking-of-fibroblast-like-synoviocytes-amplifies-synovial-inflammation-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology